What sector does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) operate in?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) current stock price?
As of the latest data, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd stock price is HK$2.61, with a previous close of HK$2.64. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd lost -HK$0.03 in the last trading session, representing a -1.14% loss.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) current market capitalization?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd market cap is approximately 887.40 million.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) Earnings Per Share (EPS)?
The trailing EPS is HK$0.09.
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) Price-to-Earnings (P/E) ratio?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd current P/E ratio is 28.94.
Does Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) dividends?
Yes. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd pays semiannual dividends with a forward yield of 5.8% and a forward payout of HK$0.15 per share.
When is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349) next earnings report?
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is expected to release its next earnings report on March 31, 2025.